Douglas W. Green et al., Antisense Oligionucleotides: An Evolving Technology for the Modulation of Gene Expression in Human Disease, American College of Surgeons, pp. 93-105.* |
Kuang-Yu Jen et al., Suppression of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Strategies, Stem Cells 2000, 18, pp. 307-319.* |
Sudhir Agrawal et al., Antisense therapeutics: is it as simple as complementary base recognition? Molecular Medicine Today, Feb. 2000, vol. 6, pp. 72-81.* |
Andrea D. Branch, A good antisense molecule is hard to find, TIBS 23—Feb. 1998, pp. 45-50.* |
W. Michael Flanagan et al., Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide, Research, pp. 1-5.* |
D.D.F. Ma et al., Synthetic oligonucleotides as therapeutics: the coming of age, Biotechnology Annual Review, vol. 5, pp. 155-196.* |
C. Frank Bennett et al., Pharmacology of Antisense Therapeutic Agents, pp. 13-46.* |
Aragane et al., IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines, J. Immunol., 1994, 153:5366-5372. |
Berrebi et al., Interleukin-12 expression is focally enhanced in the gastric mucosa of pediatric patients with Crohn's disease, Am. J. Pathol., 1998, 152:667-672. |
Carter et al., Production and characterization of monoclonal antibodies to human interleukin-12, Hybridoma, 1997, 16:363-369. |
Chen et al., Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer, J. Immunol., 1997, 159:351-359. |
D'Andrea et al., Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells, J. Exp. Med., 1992, 176:1387-1398. |
Gearing et al., Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor, Cell, 1991, 66:9-10. |
Gillessen et al., Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist, Eur. J. Immunol., 1995, 25:200-206. |
Gubler et al., Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor, Proc. Natl. Acad. Sci. U S A, 1991, 88:4143-4147. |
Hall, IL-12 at the crossroads, Science, 1995, 268:1432-1434. |
Heinzel et al., Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon, Infect. Immun., 1994, 62:4244-4249. |
Huaux et al., Lung Fibrosis Induced by Silica Particles in NMRI Mice Is Associated with an Upregulation of the p40 Subunit of Interleukin-12 and Th-2 Manifestations, Am. J. Respir. Cell Mol. Biol., 1999, 20:561-572. |
Larsson et al., Effects of a corticosteroid, budesonide, on production of bioactive IL-12 by human monocytes, Cytokine, 1998, 10:786-789. |
Lieschke et al., Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo, Nat. Biotechnol., 1997, 15:35-40. |
Ling et al., Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity, J. Immunol., 1995, 154:116-127. |
Merberg et al., Sequence similarity between NKSF and the IL-6/G-CSF family, Immunol. Today, 1992, 13:77-78. |
Pagenstecher et al., Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis, J. Immunol., 2000, 164:4481-4492. |
Rothe et al., Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12 (p40)2, Diabetologia, 1997, 40:641-646. |
Sieburth et al., Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5, Genomics, 1992, 14:59-62. |
Snijders et al., Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of p35 subunit, J. Immunol., 1996, 156:1207-1212. |
Warbrick et al., Analysis of interleukin 12 protein production and mRNA expression in mice exposed topically to chemical allergens, Toxicology, 1999, 132:57-66. |
Zou et al., Structure-function analysis of the p35 subunit of mouse interleukin 12, J. Biol. Chem., 1995, 270:5864-5871. |